Lilly Asia Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 6
Professionals
  • Investments
  • 172
  • Portfolio
  • 80
  • Exits
  • 39
Exits

Lilly Asia Ventures General Information

Description

Lilly Asia Ventures is a venture capital firm. The firm makes venture capital investments in the life sciences and healthcare sectors in Asia, with a focus on China. It was founded in 2008 and is based in Shanghai, China.

Contact Information

Year Founded
2008
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • Room 2909-14, No.168 Hubin Road
  • Huangpu District
  • Shanghai, 200021
  • China
+86 00000000000

Lilly Asia Ventures Investments (172)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Insilico Medicine 22-Jun-2021 Later Stage VC 00000 Drug Discovery Generating Revenue
000000 18-Jun-2021 00000 00000 Diagnostic Equipment Generating Revenue
0000000 0000000000 17-Jun-2021 000 00000 Biotechnology Clinical Trials - General
0000000000 10-Jun-2021 00000 00000 00000 Drug Discovery Pre-Clinical Trials
000000 00000000000 26-May-2021 00000 00000 00000 Drug Discovery Clinical Trials - General
00000 000000 25-May-2021 00000 00000 000.00 Therapeutic Devices Generating Revenue
0000000 000000000 20-May-2021 00000 00000 0000 Drug Discovery Pre-Clinical Trials
00000000000 13-May-2021 00000 00000 00000 Pharmaceuticals Generating Revenue 000000 000
Alebund Pharmaceuticals 10-May-2021 Early Stage VC 0000 Biotechnology Pre-Clinical Trials
Scivita Medical 26-Apr-2021 Early Stage VC 000.00 Machinery (B2B) Generating Revenue
You’re viewing 10 of 172 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lilly Asia Ventures Exits (39)

Company Name Exit Date Exit Type Exit Size
ACEA Therapeutics 01-Jun-2021 Merger/Acquisition 0000
0000 06-May-2021 000 000.00
0000000 0000000000 19-Mar-2021 000 00000
00000 000000000000 05-Feb-2021 000 00000
00000 0000000000 27-Jan-2021 000 00000
0000000 000 22-Jan-2021 000000 0000000000 00000
0000000 08-Jan-2021 000 00000
000000 0000000 07-Dec-2020 000000000000000000
Allist Pharmaceuticals 02-Dec-2020 IPO 00000
ReadCoor 13-Oct-2020 Merger/Acquisition 00000
You’re viewing 10 of 39 exits. Get the full list »

Lilly Asia Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Lilly Asia Ventures‘s full profile, request access.

Request a free trial

Lilly Asia Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Lilly Asia Ventures Team (9)

Name Title Deals Funds Boards Office
Yi Shi Ph.D Founder & Managing Partner 0 0 0 Shanghai, China
Fei Chen Ph.D Managing Partner 0 0 Shanghai, China
Jimmy Zhang Partner 0 Shanghai, China
Judith Li Partner 00 0 0 Shanghai, China
Stephen Lin Partner 0 0 Shanghai, China
You’re viewing 5 of 9 team members. Get the full list »

Lilly Asia Ventures Co-Investors (301)

Name With Exits Lead Partner Series Industry
OrbiMed 21 0 00 Series chart Industry bar
Qiming Venture Partners 00 0 0 Series chart Industry bar
Hillhouse Capital Group 00 0 Series chart Industry bar
Vivo Capital 00 0 Series chart Industry bar
Sequoia Capital China 0 0 Series chart Industry bar
You’re viewing 5 of 301 co-investors. Get the full list »